Dyne Therapeutics Inc (DYN)

EBITDA Growth

-20.55%

TTM · Period ending:

DYN logo

DYN EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-20.55%
DYN TTM EBITDA YoY % (24.29% → -20.55%)
High-resolution chart · PNG

DYN ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Dyne Therapeutics Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-20.5521%
-18.3018%
-36.4905%
-42.9964%
-60.5171%
-42.8497%
-34.7817%
-40.9707%
-35.4578%
-45.0252%
-39.6648%
-15.7901%
-4.5406%
-11.1699%
-13.0512%
-43.234%
-87.1954%
-109.946%
-154.3134%
-255.4074%
-252.4214%
-258.8431%
-270.9136%
97.4939%
97.6714%
98.0328%
47.2393%
698.0645%
1,920%
90.8629%
-38.2576%
-147.4006%
-122.0418%
146.25%
-12.5828%
253.5135%
81.0924%
4.8035%
101.3333%
-83.2123%
-77.7778%
209.4595%
42.8571%
142.9965%
141.0345%
104.5963%
107.3018%
-527.8798%
-481.0219%
-275.4183%
-249.2001%
-3.5126%
15.9433%
4,930.5592%
3,469.6527%
121.7165%
7.8114%
-101.8112%
-97.0067%
-63.2063%
-26.1456%
24.2891%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.